medigraphic.com
ISSN 1561-3054 (Electronic)

2022, Number 1

<< Back Next >>

Rev Cubana Med Trop 2022; 74 (1)

Multiple infections by Alphapapillomavirus, specie 9, in Ecuadorian women with intraepithelial lesions and cervical cancer

Bedoya PCH, Soto BY, Espinosa GM, Chedraui AP, Escobar VGS, Loja CR, Sánchez GS, Kourí CV

Language: Spanish
References: 33
Page:
PDF size: 561.17 Kb.


ABSTRACT

Introduction: It is still controversial the biological connotation of multiple infections with high-risk human papillomaviruses (hrHPV), that belong to the genus Alphapapillomavirus, for the cervical carcinogenesis.
Objective: To provide information on the circulation of hrHPV, genus Alphapapillomavirus, specie 9, and the multiple infections in Ecuadorian women with intraepithelial lesions and cervical cancer.
Methods: 300 women, from the coastal region of Ecuador, were screened. Viral infection was detected in cervix samples by nested PCR with MY09/11 and GP5/GP6 generic primers. Viral genotypes were identified using the commercial kit ANYPLEX II VPH28. The prevalence ratio (PR) was used to measure the association between cytological lesions and the simple, multiple or combined genotype infections.
Results: Ninety-two percent of women (276/300) tested positive for HPV. Frequency of infection for single genotypes was high, mainly those of high oncogenic risk. The most frequent hrHPV genotypes were HPV58 (18.17%), 70 (8.64%), 53 (8.34%), 35 (7.45%), 16 (7.37%), 33 (6.55%), 31 (5.58%) and 18 (4.24%). In 91.66% (253/300) of the samples, multiple infections were detected, with up to 13 types in a single patient, including various species from the genus Alphapapillomavirus. The combination HPV16/HPV58 was the most frequent on high-grade lesions (PR = 2.9; p = 0,000), and HPV16/HPV58/HPV70 triple co-infection prevailed in women with cervical cancer (PR = 3.5; p = 0.007).
Conclusions: The results evidence that the combination HPV16/HPV58, genus Alphapapillomavirus, specie 9, could be a key factor in the occurrence of premalignant lesions and their evolution into cervical cancer.


REFERENCES

  1. Zur Hausen H. Papillomavirus infections -a major cause of human cancers. Biochim Biophys Acta. 1996 [Acceso 10/09/2020];1288(2):F55-78. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/abs/pii/0304419X96000200?via%3Dihub

  2. Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, et al. Human Papillomavirus and Related Diseases in the World. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre); 2021. [Acceso 10/06/2021]. Disponible en: Disponible en: https://hpvcentre.net/statistics/reports/XFX.pdf

  3. Bzhalava D, Eklund C, Dillner J. International standardization and classification of human papillomavirus types. Virology. 2015 [Acceso 12/09/2020];476:341-4. Disponible en: Disponible en: https://www.sciencedirect.com/sdfe/reader/pii/S0042682214005777/pdf

  4. Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, et al. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. Cancer Epidemiol Biomarkers Prev. 2014 [Acceso 12/09/2020];23(10):1997-2008. Disponible en: Disponible en: https://cebp.aacrjournals.org/content/cebp/23/10/1997.full.pdf

  5. Picconi MA, Villa LL. Human Papillomavirus Research in Latin America. In: Ludert JE, Pujol FH, Arbiza J, eds. Human Virology in Latin America. Buenos Aires: Springer International Publishing; 2017. [Acceso 09/10/2020]. Disponible en: Disponible en: https://www.springer.com/fr/product-marketing-tool/flyer/9783319545660?downloadType=BOOKSELLERFLYER

  6. Molina-Pineda A, López-Cardona MG, Limón-Toledo LP, Cantón-Romero JC, Martínez-Silva MG, Ramos-Sánchez HV, et al. High frequency of HPV genotypes 59, 66, 52, 51, 39 and 56 in women from Western Mexico. BMC Infect Dis. 2020 [Acceso 09/10/2020];20(1):889. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690193/pdf/12879_2020_Article_5627.pdf

  7. Batista JE, Saddi VA, Carvalho KPA, Ribeiro AA, Segati KD, Carneiro M, et al. Human papillomavirus genotypes 68 and 58 are the most prevalent genotypes in women from quilombo communities in the state of Maranhao, Brazil. Int J Infect Dis. 2017 [Acceso 09/10/2020];55:51-5. Disponible en: Disponible en: https://www.sciencedirect.com/sdfe/reader/pii/S1201971217300048/pdf

  8. Colpani V, Soares Falcetta F, Bacelo Bidinotto A, Kops NL, Falavigna M, Serpa Hammes L, et al. Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis. PLoS One. 2020;15(2):e0229154. DOI: https://doi.org/10.1371/journal.pone.0229154

  9. Chiesa IJ, Perez MS, Nuñez GG, Pirola DA. Genetic variability and phylogeny analysis of partial L1 gene of human papillomavirus variants in Buenos Aires, Argentina. Virusdisease. 2016 [Acceso 08/11/2020];27(1):41-7. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758316/pdf/13337_2015_Article_295.pdf

  10. Mejía L, Muñoz D, Trueba G, Tinoco L, Zapata S. Prevalence of human papillomavirus types in cervical cancerous and precancerous lesions of Ecuadorian women. J Med Virol. 2016;88(1):144-52. DOI: https://doi.org/10.1002/jmv.24310

  11. Molet L, Girlich D, Bonnin RA, Proust A, Bouligand J, Bachelerie F, et al. Identification by high-throughput sequencing of HPV variants and quasispecies that are untypeable by linear reverse blotting assay in cervical specimens. Papillomavirus research (Amsterdam, Netherlands). 2019 [Acceso 08/11/2020];8:100169. Disponible en: Disponible en: https://www.mdpi.com/2076-2607/9/4/729/htm

  12. Lee YJ, Kim D, Lee K, Chun JY. Single-channel multiplexing without melting curve analysis in real-time PCR. Sci Rep. 2014 [Acceso 15/11/2020];4:7439. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262828/pdf/srep07439.pdf

  13. Marcuccilli F, Farchi F, Mirandola W, Ciccozzi M, Paba P, Bonanno E, et al. Performance evaluation of Anyplex™ II HPV28 detection kit in a routine diagnostic setting: comparison with the HPV Sign® Genotyping Test. J Virol Methods. 2015 [Acceso 15/11/2020];217:8-13. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343909/pdf/pone.0210997.pdf

  14. Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, et al. Human Papillomavirus and Related Diseases in Ecuador. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre); 2020. [Acceso 15/11/2020]. Disponible en: Disponible en: https://hpvcentre.net/statistics/reports/ECU.pdf

  15. Bedoya-Pilozo CH, Medina Magües LG, Espinosa-García M, Sánchez M, Parrales Valdiviezo JV, Molina D, et al. Molecular epidemiology and phylogenetic analysis of human papillomavirus infection in women with cervical lesions and cancer from the coastal region of Ecuador. Rev Argent Microbiol. 2018 [Acceso 20/11/2020];50(2):136-46. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S0325754117301372?via%3Dihub

  16. Carrión-Ordoñez JI, Soto-Brito Y, Escandón F, García-Pupo L, Pupo-Antúnez M. Human papillomavirus infection and associated risk factors in Ecuadorian women from two communities of Cañar province. J Cervical Cancer Res. 2020 [Acceso 20/11/2020];3(1):307-17. Disponible en: Disponible en: https://scholars.direct/Articles/cervical-cancer/jccr-3-005.pdf?jid=cervical-cancer

  17. Nayar R, Wilbur DC. The Bethesda System for Reporting Cervical Cytology. 3rd ed. Nayar R, Wilbur DC, eds. Chicago, IL: Springer; 2014. 342 p. [Acceso 20/11/2020]. Disponible en: Disponible en: http://fosp.saude.sp.gov.br:443/docs/The+Bethesda+System+for+Reporting+Cervic.pdf

  18. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000 [Acceso 10/12/2020];38(1):357-61. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC88724/pdf/jm000357.pdf

  19. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995 [Acceso 10/12/2020];76(4):1057-62. Disponible en: Disponible en: https://www.microbiologyresearch.org/content/journal/jgv/10.1099/0022-1317-76-4-1057#tab2

  20. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-94. DOI: https://doi.org/10.1001/jama.2013.281053

  21. van Delden J, van der Graaf R. Revised CIOMS International Ethical Guidelines for Health-Related Research Involving Humans. JAMA. 2017;317(2):135-6. DOI: https://doi.org/10.1001/jama.2016.18977

  22. Guo M, Khanna A, Wang J, Dawlett MA, Kologinczak TL, Lyons GR, et al. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening. Cancer Cytopathol. 2017 [Acceso 10/12/2020];125(8):644-51. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555795/pdf/nihms871451.pdf

  23. Pimple SA, Mishra GA, Deodhar KK. Evidence based appropriate triage strategies for implementing high risk HPV as primary technology in cervical cancer screening. Minerva Ginecol. 2020;72(2):96-105. DOI: https://doi.org/10.23736/S0026-4784.20.04511-6

  24. Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening and Vaccination-Review of Current Perspectives. J Oncol. 2019 Oct 10;2019:3257939. DOI: https://doi.org/10.1155/2019/3257939

  25. Adcock R, Cuzick J, Hunt WC, McDonald RM, Wheeler CM. Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia. Cancer Epidemiol Biomarkers Prev. 2019 [Acceso 10/12/2020];28(11):1816-24. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394698/pdf/nihms-1730809.pdf

  26. Romero-Morelos P, Uribe-Jimenez A, Bandala C, Poot-Velez A, Ornelas-Corral N, Rodriguez-Esquivel M. Genotyping of human papilloma virus in a group of Mexican women treated in a highly specialist hospital: Multiple infections and their potential transcendence in the current vaccination programme. Med Clin (Barc). 2017 [Acceso 10/12/2020];149(7):287-92. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S2387020617305818

  27. Chan PK, Ho WC, Chan MC, Wong MC, Yeung AC, Chor JS, et al. Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide. PLoS One. 2014 [Acceso 10/12/2020];9(9):e107573. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168000/pdf/pone.0107573.pdf

  28. Campoverde A, Arcentales M, Caguana J. Caracterización de los genotipos frecuentes del virus del papiloma humano en mujeres atendidas en los hospitales monte SINAI y del seguro social Cuenca-Ecuador. 2008-2014. Rev Fac Cien Méd Univ Cuenca. 2017 [Acceso 10/12/2020];(1):7-19. Disponible en: Disponible en: http://dspace.ucuenca.edu.ec/handle/123456789/27478

  29. Tornesello ML, Buonaguro L, Izzo S, Lopez G, Vega X, Maldonado Reyes CF, et al. A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women. J Med Virol. 2008 [Acceso 10/12/2020];80(11):1959-65. Disponible en: Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.21317

  30. Wentzensen N, Nason M, Schiffman M, Dodd L, Hunt WC, Wheeler CM. No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study. J Infect Dis. 2014 [Acceso 10/12/2020];209(6):855-64. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935473/pdf/jit577.pdf

  31. De Brot L, Pellegrini B, Moretti ST, Carraro DM, Soares FA, Rocha RM, et al. Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix. Cancer Cytopathol. 2017 [Acceso 10/12/2020];125(2):138-43. Disponible en: Disponible en: https://reproductive-health-journal.biomedcentral.com/track/pdf/10.1186/s12978-021-01244-2.pdf

  32. Salazar KL, Zhou HS, Xu J, Peterson LE, Schwartz MR, Mody DR, et al. Multiple Human Papilloma Virus Infections and their Impact on the Development of High-Risk Cervical Lesions. Acta Cytol. 2015 [Acceso 10/12/2020];59:391-8. Disponible en: Disponible en: https://www.karger.com/Article/Pdf/442512

  33. Sobota RS, Ramogola-Masire D, Williams SM. Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer. Infect Agent Cancer. 2018 [Acceso 10/12/2020];9(2):26-30. Disponible en: Disponible en: https://infectagentscancer.biomedcentral.com/track/pdf/10.1186/1750-9378-9-26.pdf




2020     |     www.medigraphic.com